let mcqs_data = [
  {
    question:
      "In which measures of remission did RINVOQ with or without MTX achieve a higher response rate compared with the control group in the SELECT-COMPARE and SELECTMONOTHERAPY trials?<sup>1</sup>",
    options: [
      { 1: "DAS28-CRP &#60; 2.6" },
      { 2: "CDAI ≤ 2.8" },
      { 3: "SDAI ≤ 3.3" },
      { 4: "All of the above" },
    ],
    rightAns: "option4",
    id: 1,
    rightAnsId: "que1-opt4",
  },

  {
    question:
      "RINVOQ + MTX has demonstrated durable remission rates (DAS28 [CRP] <2.6) through how many year(s)?",
    options: [
      { 1: "option-1" },
      { 2: "option-2" },
      { 3: "option-3" },
      { 4: "option-4" },
    ],
    rightAns: "option2",
    id: 2,
    rightAnsId: "que2-opt2",
  },

  {
    question:
      "RINVOQ + MTX was superior to adalimumab + MTX at Week 12 in which of the following outcomes in the SELECT-COMPARE trial?",
    options: [
      { 1: "option-A" },
      { 2: "option-B" },
      { 3: "option-C" },
      { 4: "option-D" },
    ],
    rightAns: "option1",
    id: 3,
    rightAnsId: "que3-opt1",
  },

  {
    question:
      "In SELECT-PsA 1, a significantly greater proportion of patients treated with RINVOQ achieved the primary endpoint of ACR20 response compared with placebo at Week 12. In the trial, how many patients achieved minimal disease activity with RINVOQ at Week 24 and 2 years?",
    options: [
      { 1: "XXX" },
      { 2: "YYY" },
      { 3: "ZZZ" },
      { 4: "XYZ" },
    ],
    rightAns: "option3",
    id: 4,
    rightAnsId: "que4-opt3",
  },
];

export default mcqs_data;
